期刊
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL
卷 19, 期 -, 页码 153-160出版社
ELSEVIER
DOI: 10.1016/j.csbj.2020.12.016
关键词
Transcriptome sequencing; COVID-19; Disease severity; Expression signature; Nasopharyngeal swabs
资金
- College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences
Characterizing key molecular and cellular pathways involved in COVID-19 is crucial for disease prognosis and management. Transcriptome analysis of nasopharyngeal swabs of patients revealed dysregulated immune related pathways, especially in patients with severe symptoms, suggesting the excessive release of cytokines and chemokines may contribute to the severity of the disease. Differential gene expression analysis identified a small set of regulatory genes that could act as strong predictors of patient outcome.
Characterizing key molecular and cellular pathways involved in COVID-19 is essential for disease prognosis and management. We perform shotgun transcriptome sequencing of human RNA obtained from nasopharyngeal swabs of patients with COVID-19, and identify a molecular signature associated with disease severity. Specifically, we identify globally dysregulated immune related pathways, such as cytokine-cytokine receptor signaling, complement and coagulation cascades, JAK-STAT, and TGF-beta signaling pathways in all, though to a higher extent in patients with severe symptoms. The excessive release of cytokines and chemokines such as CCL2, CCL22, CXCL9 and CXCL12 and certain interferons and interleukins related genes like IFIH1, IFI44, IFIT1 and IL10 were significantly higher in patients with severe clinical presentation compared to mild and moderate presentations. Differential gene expression analysis identified a small set of regulatory genes that might act as strong predictors of patient outcome. Our data suggest that rapid transcriptome analysis of nasopharyngeal swabs can be a powerful approach to quantify host molecular response and may provide valuable insights into COVID-19 pathophysiology. (C) 2020 The Author(s). Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据